Javier López Pais-rekin lankidetzan egindako argitalpenak (6)

2022

  1. Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

    Medicina Clinica, Vol. 158, Núm. 7, pp. 315-323

  2. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  3. Transcatheter aortic valve replacement in obese patients: procedural vascular complications with the trans-femoral and trans-carotid access routes

    Interactive cardiovascular and thoracic surgery, Vol. 34, Núm. 6, pp. 982-989

2021

  1. Impact of morbid obesity and obesity phenotype on outcomes after transcatheter aortic valve replacement

    Journal of the American Heart Association, Vol. 10, Núm. 12

  2. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

    Cardiology journal, Vol. 28, Núm. 3, pp. 360-368

  3. The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients

    Scientific Reports, Vol. 11, Núm. 1